Form D · Biotechnology

Naked Biome, Inc.

San Francisco, CA · CIK 0001683849

Offering snapshot reported May 15, 2019 · SEC filing

Reported sold: $6.11M
Investors reported: 18
Minimum accepted: $1
First sale: Sep 2, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,207,338 → $6,107,333
Reported investors13 → 18

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 15, 2019	Amendment	$6,107,333	$1,899,995vs Sep 15, 2016	18	SEC filing
Apr 9, 2018	Initial	$1,656,250	No comparison	11	SEC filing
Dec 28, 2016	Amendment	$4,307,337	$99,999vs Sep 15, 2016	15	SEC filing
Sep 15, 2016	Initial	$4,207,338	No comparison	13	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-270756

$5,619,988.37 in new money; $487,345.19 in conversion of promissory notes.

Source: Form D, filed May 15, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Peter Di Laura	Director
Emma Taylor	Director, Executive
Brian Varnum	Director
Greg Vontz	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

953 Indiana St.
San Francisco, CA, 94107